Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?
about
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheMicroarrays bring new insights into understanding of breast cancer metastasis to boneRelative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.Metastatic cancer stem cells: from the concept to therapeuticsIdentification of ovarian cancer metastatic miRNAsGenes that mediate breast cancer metastasis to lungThe inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151.Can a metastatic gene expression profile outperform tumor size as a predictor of occult lymph node metastasis in oral cancer patients?Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting alpha 3 integrin.Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk.Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesMolecular signatures of metastasis in head and neck cancer.An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosisCUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.Breast cancer subtyping from plasma proteins.Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.KDM5B is overexpressed in gastric cancer and is required for gastric cancer cell proliferation and metastasis.Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen.Signaling pathways in breast cancer metastasis - novel insights from functional genomicsDynamics of preventive vs post-diagnostic cancer control using low-impact measures.Integrin alpha(v)beta(3) as a target in the prevention of neointimal hyperplasia.Metastasis suppressors and their roles in breast carcinoma.Functional genomic analysis of cancer metastasis: biologic insights and clinical implications.Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.SPAG9 controls the cell motility, invasion and angiogenesis of human osteosarcoma cells.Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.Early and multiple origins of metastatic lineages within primary tumorsSPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression.Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.Impact of CCL2 and Its Receptor CCR2 Gene Polymorphism in North Indian Population: A Comparative Study in Different Ethnic Groups Worldwide.Saussurea lappa Clarke-Derived Costunolide Prevents TNF α -Induced Breast Cancer Cell Migration and Invasion by Inhibiting NF- κ B ActivityGene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases.Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas.Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway.Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.
P2860
Q24600542-94BAFB82-7840-43DF-8E3F-EEB8385B7ABEQ24794044-225C5A98-8943-4640-B980-5A31C86EAC70Q24797550-8D34C10E-47C8-41C3-A76A-E1E09A1FD2C5Q26850739-9DD66CF7-7083-4CF5-9B13-AFB52FD5BF0AQ28487932-5E945729-B7CC-4427-8DBE-3B3E365ACD9AQ29547479-14E2D57B-956F-4C97-8055-98197EA49CC1Q30499283-6A78ED54-EB95-4D20-A02F-BF77232A3961Q30499736-F9FCA063-3520-48E1-A9AC-8C5327C0492DQ33224181-A5142329-A597-4AEB-B6A9-F540000A6B18Q33361310-EB1C3F9B-52E0-4109-B812-093A5469469FQ33394405-BEDA8193-8092-46B5-BE8D-7244D0741E7BQ33553570-D5F1F2AA-E108-4F9F-9F8F-81951CBD0517Q33730375-4FB61DAC-81C5-459A-9CA0-A75B0200EC64Q34060131-55C61728-F7BD-4976-BA19-0C8AAA92941EQ34491930-E0F0E1F6-F7E9-4C56-AE91-622581B805CAQ34534040-23E795F1-A21D-45DA-BC8F-962BF8C32510Q34570193-D3A545DC-AA6A-4FF4-8F96-8DA170471CAEQ34600828-AE2D9E24-DD37-4293-B7CA-CFDF1D53BE6FQ34805590-9C1F1EA5-9BE6-48F1-85C1-76CBC884651BQ34991245-3BE41E07-36D3-4E59-845C-A33E1C1BAE12Q35088252-014B1303-29C8-43D5-B862-3D8D79B9416CQ35558904-34C622D2-2E10-42F6-BE14-B0ADF8F1E0C6Q35914889-7208C412-5966-4BA4-BCFF-B2B29D8ACB0DQ35925211-CB27F7E3-CE57-46B4-ADB2-D6B2C69116A4Q35981102-57254FB3-EB75-41F5-B61C-BF285D77D207Q36150368-968A2E94-F2D6-4DE7-89EB-1304EA2422F2Q36362003-BA2DF4DC-A56C-47E5-B7A7-CE98541C69D4Q36524476-D425B861-6AC6-4D2F-AE6E-EE49EC7299A7Q36561645-04A12B7E-D72A-488B-A9FD-0BD430732669Q36646666-7B924B38-1F4C-4ADD-A878-C5B924F590FCQ36657565-8BB113A3-8BD5-49CE-BC67-6100B74383C7Q36882732-5D87553C-2D37-493F-A407-616B66270161Q36946216-151045BD-0B9E-4BB9-8B18-482337C1CB48Q37127262-81905F7F-ED7B-497F-A65C-07B4F4FF44DFQ37375070-7176C889-1D82-43C3-BA2E-63C7266A01D3Q37410368-620E9AF5-94C9-4CA8-9270-13F78BE0F696Q37628092-9C949B97-BCB5-4E80-A48A-4A53EE45623BQ37696353-E41F885C-018A-4EE4-9A7A-AF32D5992ED6Q37708946-548D2F1C-7E41-4B94-BE64-ABF097B7CAE7Q37860966-BA80BA1E-B4ED-47AC-BF5A-52796C3A7F64
P2860
Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Metastatic potential: generic ...... , metastatic variants-or both?
@ast
Metastatic potential: generic ...... , metastatic variants-or both?
@en
type
label
Metastatic potential: generic ...... , metastatic variants-or both?
@ast
Metastatic potential: generic ...... , metastatic variants-or both?
@en
prefLabel
Metastatic potential: generic ...... , metastatic variants-or both?
@ast
Metastatic potential: generic ...... , metastatic variants-or both?
@en
P1433
P1476
Metastatic potential: generic ...... , metastatic variants-or both?
@en
P2093
Richard O Hynes
P304
P356
10.1016/S0092-8674(03)00468-9
P407
P577
2003-06-01T00:00:00Z